This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bcworld Pharm. Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovator Wonkyung Cho and His Contributions to Liposome Technology.
Introduction
Wonkyung Cho is a notable inventor based in Jeonbuk, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the preparation of liposomes. His innovative approach has the potential to enhance the delivery of bioactive components in various applications.
Latest Patents
Wonkyung Cho holds a patent for a "Method and apparatus for preparing novel liposome." This patent discloses a method for preparing a liposome formulation by dissolving a lipid fraction in an organic solvent. The process involves combining a solution that includes a bioactive component and the lipid fraction with a carrier in a reaction vessel. A supercritical fluid is introduced to prepare particles coated with the bioactive component-lipid. The supercritical fluid is then discharged by compression to obtain proliposome particles, which are subsequently hydrated with an aqueous solution to form a liposome solution. This method can be easily implemented at a laboratory scale and is also suitable for mass production.
Career Highlights
Cho is currently associated with Bcworld Pharm. Co., Ltd., where he continues to develop innovative pharmaceutical solutions. His work focuses on enhancing the efficacy of drug delivery systems through advanced liposome formulations.
Collaborations
Some of his notable coworkers include Donggeon Gu and Kwang-Ho Cha, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Wonkyung Cho's innovative methods in liposome preparation represent a significant advancement in pharmaceutical technology. His contributions are poised to impact the efficiency of drug delivery systems positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile